Get the Stockscreener App
306.86
2.39%
-7.52
After Hours:
306.94
0.08
+0.03%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $306.86, with a volume of 2.49M.
It is down -2.39% in the last 24 hours and down -2.78% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$314.38
Open:
$313.98
24h Volume:
2.49M
Relative Volume:
0.82
Market Cap:
$164.61B
Revenue:
$33.42B
Net Income/Loss:
$4.09B
P/E Ratio:
40.64
EPS:
7.55
Net Cash Flow:
$10.39B
1W Performance:
-3.70%
1M Performance:
-2.78%
6M Performance:
-1.92%
1Y Performance:
+9.27%
1-Day Range:
$303.51
$314.22
1-Week Range:
$303.51
$318.92
52-Week Range:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
306.86 | 164.61B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
852.35 | 765.56B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
201.34 | 355.44B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
161.02 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
73.60 | 334.39B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
87.87 | 235.20B | 64.17B | 17.12B | 18.10B | 6.73 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Gutierrez Wealth Advisory LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biotech Stocks Slide Due to Tariff Concerns (AMGN) - GuruFocus.com
Why Pharma and Biotech Stocks Got Thrashed on Tuesday - The Motley Fool
Amgen Options Trading: A Deep Dive into Market Sentiment - Benzinga
Amgen Inc. (NASDAQ:AMGN) is Sector Gamma AS's 9th Largest Position - MarketBeat
Prudential Financial Inc. Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Corebridge Financial Inc. Has $42.31 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Analysts Set Amgen Inc. (NASDAQ:AMGN) Target Price at $314.04 - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Makes New $219,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out - Law360
Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Amgen Seeks to Toss $50 Million Blincyto Loss on Lindis Patents - Bloomberg Law
Emerald Advisers LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Congress Wealth Management LLC DE Has $19.02 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Vanguard Group Inc. Boosts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Crowley Wealth Management Inc. Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Napatree Capital LLC Buys 1,059 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Stevens Capital Management LP Buys Shares of 6,849 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Knights of Columbus Asset Advisors LLC Sells 1,182 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Samalin Investment Counsel LLC Sells 1,015 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sei Investments Co. Sells 89,525 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,355 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by AXQ Capital LP - MarketBeat
Teacher Retirement System of Texas Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
iA Global Asset Management Inc. Has $15.10 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Harvest Fund Management Co. Ltd Grows Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Is Amgen Inc. (AMGN) The Best Healthcare Dividend Stock to Invest in? - Insider Monkey
180,316 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by KLP Kapitalforvaltning AS - MarketBeat
3,996 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Forefront Wealth Management Inc. - MarketBeat
Mizuho Securities USA LLC Boosts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
2,176 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by ZEGA Investments LLC - MarketBeat
Summit Global Investments Makes New $3.69 Million Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Virtu Financial LLC - MarketBeat
HUB Investment Partners LLC Sells 1,017 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Blueshift Asset Management LLC Purchases Shares of 1,325 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
7,472 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Madison Investment Advisors LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Reduced by Boston Partners - MarketBeat
Thrivent Financial for Lutherans Has $129.13 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
TD Private Client Wealth LLC Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Antonelli Financial Advisors LLC Buys New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Trimmed by DCF Advisers LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Holderness Investments Co. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Royal London Asset Management Ltd. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) is Primecap Management Co. CA's 4th Largest Position - MarketBeat
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Kimelman & Baird LLC Has $3.86 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Intech Investment Management LLC Trims Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Axxcess Wealth Management LLC Has $2.74 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Why Amgen (AMGN) is a Top Value Stock for the Long-Term - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Envestnet Portfolio Solutions Inc. - MarketBeat
Magnetar Financial LLC Takes $5.27 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.26%
1.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):